These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1283389)

  • 21. Vascular targeting and the inhibition of angiogenesis.
    Bicknell R
    Ann Oncol; 1994; 5 Suppl 4():45-50. PubMed ID: 7520262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Streptopyrrolidine, an angiogenesis inhibitor from a marine-derived Streptomyces sp. KORDI-3973.
    Shin HJ; Kim TS; Lee HS; Park JY; Choi IK; Kwon HJ
    Phytochemistry; 2008 Sep; 69(12):2363-6. PubMed ID: 18649901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells.
    Tang FY; Chiang EP; Shih CJ
    J Nutr Biochem; 2007 Jun; 18(6):391-9. PubMed ID: 17049832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The modifying action of tumor necrosis factor on angiogenesis].
    Lisniak IA; Sopotsinskaia EB; Kudriavets IuI
    Eksp Onkol; 1989; 11(3):50-2. PubMed ID: 2473876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of mast cells in experimental tumour angiogenesis.
    Fraser RA; Simpson JG
    Ciba Found Symp; 1983; 100():120-31. PubMed ID: 6197256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of tumor angiogenesis by roxithromycin, a 14-membered ring macrolide antibiotic.
    Yatsunami J; Tsuruta N; Hara N; Hayashi S
    Cancer Lett; 1998 Sep; 131(2):137-43. PubMed ID: 9851245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions.
    Nakajima M; Hayashi K; Katayama K; Amano Y; Egi Y; Uehata M; Goto N; Kondo T
    Eur J Pharmacol; 2003 Jan; 459(2-3):113-20. PubMed ID: 12524136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New members of the macrosphelides from Microsphaeropsis sp. FO-5050 IV.
    Fukami A; Taniguchi Y; Nakamura T; Rho MC; Kawaguchi K; Hayashi M; Komiyama K; Omura S
    J Antibiot (Tokyo); 1999 May; 52(5):501-4. PubMed ID: 10480575
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
    Anand-Apte B; Pepper MS; Voest E; Montesano R; Olsen B; Murphy G; Apte SS; Zetter B
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):817-23. PubMed ID: 9112976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling.
    Rodrigues S; Van Aken E; Van Bocxlaer S; Attoub S; Nguyen QD; Bruyneel E; Westley BR; May FE; Thim L; Mareel M; Gespach C; Emami S
    FASEB J; 2003 Jan; 17(1):7-16. PubMed ID: 12522107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts.
    Wang S; Zheng Z; Weng Y; Yu Y; Zhang D; Fan W; Dai R; Hu Z
    Life Sci; 2004 Apr; 74(20):2467-78. PubMed ID: 15010258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
    Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
    Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor.
    Oikawa T; Hasegawa M; Shimamura M; Ashino H; Murota S; Morita I
    Biochem Biophys Res Commun; 1991 Dec; 181(3):1070-6. PubMed ID: 1722395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-invasive activity of torilin, a sesquiterpene compound isolated from Torilis japonica.
    Kim MS; Baek JH; Park MT; Sohn TK; Kim SE; Lee JJ; Kim KW
    Oncol Rep; 2001; 8(2):359-64. PubMed ID: 11182056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors.
    Favot L; Keravis T; Holl V; Le Bec A; Lugnier C
    Thromb Haemost; 2003 Aug; 90(2):334-43. PubMed ID: 12888882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of angiogenesis by mixtures of two angiogenic proteins, angiogenin and acidic fibroblast growth factor, in the chick chorioallantoic membrane.
    Fett JW; Bethune JL; Vallee BL
    Biochem Biophys Res Commun; 1987 Aug; 146(3):1122-31. PubMed ID: 2441701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Targeting angiogenesis in oncology].
    Fayette J; Soria JC; Armand JP
    Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radicicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesis.
    Oikawa T; Ito H; Ashino H; Toi M; Tominaga T; Morita I; Murota S
    Eur J Pharmacol; 1993 Sep; 241(2-3):221-7. PubMed ID: 7694864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Angiogenesis--mechanisms and therapeutic approaches].
    Battegay E
    Praxis (Bern 1994); 1995 Feb; 84(5):118-21. PubMed ID: 7533322
    [No Abstract]   [Full Text] [Related]  

  • 40. Darlucins A and B, new isocyanide antibiotics from Sphaerellopsis filum (Darluca filum).
    Zapf S; Hossfeld M; Anke H; Velten R; Steglich W
    J Antibiot (Tokyo); 1995 Jan; 48(1):36-41. PubMed ID: 7868387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.